Anti-hypertensive activity of genetically modified soybean seeds accumulating novokinin

Peptides

Volumn 29, Issue 3, 2008, Pages 331-337

  Yamada, Yuko ^a   Nishizawa, Keito ^b   Yokoo, Megumi ^a   Zhao, Hui ^a   Onishi, Kunihiko ^a   Teraishi, Masayoshi ^b   Utsumi, Shigeru ^a   Ishimoto, Masao ^b   Yoshikawa, Masaaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL AGRICULTURAL RESEARCH CENTER FOR HOKKAIDO REGION   (Japan)

Author keywords

Hypotensive activity; Novokinin; Soybean conglycinin; Spontaneously hypertensive rat; Transgenic soybean

Indexed keywords

4 NOVOKININ ALPHA'; ANTIHYPERTENSIVE AGENT; CANDESARTAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GENETIC TRANSFORMATION; HYPERTENSION; MALE; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; RAT; SITE DIRECTED MUTAGENESIS; SOYBEAN; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TRANSGENIC PLANT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOTTING, SOUTHERN; IMMUNOBLOTTING; MALE; OLIGOPEPTIDES; PLANTS, GENETICALLY MODIFIED; PROMOTER REGIONS (GENETICS); RATS; RATS, INBRED SHR; SEEDS; SOYBEAN PROTEINS; SOYBEANS;

GLYCINE MAX; RATTUS;

EID: 39649090699     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.11.018     Document Type: Article

References (30)

1. Chen Z.L., Schuler M.A., and Beachy R.N. Functional analysis of regulatory elements in a plant embryo-specific gene. Proc Natl Acad Sci USA 83 (1986) 8560-8564
2. Chiu W., Niwa Y., Zeng W., Hirano T., Kobayashi H., and Sheen J. Engineered GFP as a vital reporter in plants. Curr Biol 6 (1996) 325-330
3. De Jaeger G., Scheffer S., Jacobs A., Zambre M., Zobell O., Goossens A., Depicker A., and Angenon G. Boosting heterologous protein production in transgenic dicotyledonous seeds using Phaseolus vulgaris regulatory sequences. Nat Biotechnol 20 (2002) 1265-1268
4. Ding S.H., Huang L.Y., Wang Y.D., Sun H.C., and Xiang Z.H. High-level expression of basic fibroblast growth factor in transgenic soybean seeds and characterization of its biological activity. Biotechnol Lett 28 (2006) 869-875
5. Doyle J.J., Schuler M.A., Godette W.D., Zenger V., Beachy R.N., and Slightom J.L. The glycosylated seed storage proteins of Glycine max and Phaseolus vulgaris: structural homologies of genes and proteins. J Biol Chem 261 (1986) 9228-9238
6. Duranti M., Barbiroli A., Scarafoni A., Tedeschi G., and Morazzoni P. One-step purification of Kunitz soybean trypsin inhibitor. Protein Expr Purif 30 (2003) 167-170
7. El-Shemy H.A., Teraishi M., Khalafalla M.M., Katsube-Tanaka T., Utsumi S., and Ishimoto M. Isolation of soybean plants with stable transgene expression by visual selection based on green fluorescent protein. Mol Breed 14 (2004) 227-238
8. Fischer R., Stoger E., Schillberg S., Christou P., and Twyman R.M. Plant-based production of biopharmaceuticals. Curr Opin Plant Biol 7 (2004) 152-158
9. Giddings G., Allison G., Brooks D., and Carter A. Transgenic plants as factories for biopharmaceuticals. Nat Biotechnol 18 (2000) 1151-1155
10. Katsube T., Kurisaka N., Ogawa M., Maruyama N., Ohtsuka R., Utsumi S., and Takaiwa F. Accumulation of soybean glycinin and its assembly with the glutelins in rice. Plant Physiol 120 (1999) 1063-1074
11. Khalafalla M.M., Rhaman S.M., El-Shemy H.A., Nakamoto Y., Wakasa K., and Ishimoto M. Optimization of particle bombardment conditions by monitoring of transient sGFP(S65T) expression in transformed soybean. Breed Sci 55 (2005) 257-263
12. 4 storage protein genes in soybean. Theor Appl Genet 68 (1984) 253-257
13. Ma J.K., Barros E., Bock R., Christou P., Dale P.J., Dix P.J., Fischer R., Irwin J., Mahoney R., Pezzotti M., Schillberg S., Sparrow P., Stoger E., and Twyman R.M. European Union Framework 6 Pharma-Planta Consortium: molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Rep 6 (2005) 593-599
14. Maruyama N., Katsube T., Wada Y., Oh M.H., Barba De La Rosa A.P., Okuda E., Nakagawa S., and Utsumi S. The roles of the N-linked glycans and extension regions of soybean β-conglycinin in folding, assembly and structural features. Eur J Biochem 258 (1998) 854-862
15. Matoba N., Usui H., Fujita H., and Yoshikawa M. A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS Lett 452 (1999) 181-184
16. Matoba N., Yamada Y., and Yoshikawa M. Design of a genetically modified soybean protein preventing hypertension based on an anti-hypertensive peptide derived from ovalbumin. Curr Med Chem Cardiovasc Hematol Agents 1 (2003) 197-202
17. Maughan P.J., Philip R., Cho M.J., Widholm J.M., and Vodkin L.O. Biolistic transformation, expression, and inheritance of bovine β-casein in soybean (Glycine max). In Vitro Cell Dev Biol 35P (1999) 344-349
18. Nishizawa K., Maruyama N., Satoh R., Fuchikami Y., Higasa T., and Utsumi S. A C-terminal sequence of soybean β-conglycinin α′ subunit acts as a vacuolar sorting determinant in seed cells. Plant J 34 (2003) 647-659
19. Nochi T., Takagi H., Yuki Y., Yang L., Masumura T., Mejima M., Nakanishi U., Matsumura A., Uozumi A., Hiroi T., Morita S., Tanaka K., Takaiwa F., and Kiyono H. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free-vaccination. Proc Natl Acad Sci USA 104 (2007) 10986-10991
20. Onishi K., Matoba N., Yamada Y., Doyama N., Maruyama N., Utsumi S., and Yoshikawa M. Optimal designing of beta-conglycinin to genetically incorporate RPLKPW, a potent anti-hypertensive peptide. Peptides 25 (2004) 37-43
21. Samoylov V.M., Tucker D.M., and Parrott W.A. Soybean [Glycine max (L.) Merrill] embryogenic cultures: the role of sucrose and total nitrogen content on proliferation. In Vitro Cell Dev Biol 34P (1998) 8-13
22. Stoger E., Ma J.K.-C., Fischer R., and Christou P. Sowing the seeds of success: pharmaceutical proteins from plants. Curr Opin Biotechnol 16 (2005) 167-173
23. Sugita K., Endo-Kasahara S., Tada Y., Lijun Y., Yasuda H., Hayashi Y., Jomori T., Ebinuma H., and Takaiwa F. Genetically modified rice seeds accumulating GLP-1 analogue stimulate insulin secretion from a mouse pancreatic beta-cell line. FEBS Lett 579 (2005) 1085-1088
24. Takagi H., Hiroi T., Yang L., Tada Y., Yuki Y., Takamura K., Ishimitsu R., Kawauchi H., Kiyono H., and Takaiwa F. A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Proc Natl Acad Sci USA 102 (2005) 17525-17530
25. Tashiro M., and Maki Z. Purification and characterization of a trypsin inhibitor from rice bran. J Nutr Sci Vitaminol 25 (1979) 255-264
26. Terakawa T., Hasegawa H., and Yamaguchi M. Efficient whisker-mediated gene transformation in a combination with supersonic treatment. Breed Sci 55 (2005) 465-468
27. Utsumi S., Matsumura Y., and Mori T. In: Damodaran S., and Paraf A. (Eds). Structure-function relationships of soy proteins. In Food proteins and their applications (1997), Marcel Dekker, New York 257-291
28. Yamada Y., Matoba N., Usui H., Ohnishi K., and Yoshikawa M. Design of a highly potent anti-hypertensive peptide based on ovokinin (2-7). Biosci Biotechnol Biochem 66 (2002) 1213-1217
29. 2 receptor and prostaglandin IP receptor. Peptides 29 (2008) 412-418
30. Yang L., Tada Y., Yamamoto M.P., Zhao H., Yoshikawa M., and Takaiwa F. A transgenic rice seed accumulating an anti-hypertensive peptide educes the blood pressure of spontaneously hypertensive rats. FEBS Lett 580 (2006) 3315-3320